Anika signs up Elevess disribution in Mexico, Chile, Peru, S Korea

Massachusetts, USA-based Anika Therapeutics, which focuses on products for tissue protection, healing and repair based on hyaluronic acid technology, has signed exclusive agreements with three new dermatology focused distributors to market Elevess in Mexico, Chile, Peru and South Korea. The product is an injectable filler that reduces the appearance of lines and wrinkles on the face, and was the first HA-based dermal filler approved by the US Food and Drug Administration to incorporate the anesthetic lidocaine to improve patient comfort. The agreements provide exclusive distribution rights for Elevess in each of these growing markets.

"Since its introduction in August, the worldwide market interest in Elevess has been intense," said Anika chief executive Charles Sherwood. "We are excited to partner with these new distributors in Asia and Latin America. Each of these new partners is a leader in the dermatology field in their respective countries and we look forward to their success with Elevess," he added.

"This global expansion of our markets has been a key goal for Anika since we first developed Elevess," Dr Sherwood continued. "This product fills an important niche in the HA-based dermal filler marketplace as it is easier to use for physicians, and more comfortable, long-lasting and affordable for patients. We continue to be in contact with dermatology product distributors around the world who have expressed their interest in adding this unique product to their portfolio," he said.